🔎 Trials Near Me

Akèy › Kansè tete negatif triple › Missouri › Kansas City

Etid klinik pou Kansè tete negatif triple nan Kansas City, MO

6 etid pou Kansè tete negatif triple ap chèche patisipan nan sit nan ak bò kote Kansas City (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

Ap rekriteFaz 3
  • Saint Luke's Cancer Institute ( Site 0059), Kansas City
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT06966700

A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors

Ap rekriteFaz 1
  • University of Kansas, Westwood · 5 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 17, 2026 · NCT07020117

Triple Negative Breast Cancer and Germline Hereditary Breast and Ovarian Cancer Mutation Carrier Registry

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • Universtiy Health, Kansas City
  • KCCC South, Kansas City
  • Research Medical Center, Kansas City
  • ak 2 plis
Tout laj · Tout sèks · Mizajou Aug 18, 2026 · NCT02302742

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

Ap rekriteFaz 1/2
  • University of Kansas Medical Center (KUMC), Westwood · 5 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Aug 4, 2026 · NCT05579366

A Study of Sacituzumab Govitecan Given at an Alternative Dose and Schedule in Participants With Advanced Triple-Negative Breast Cancer

Ap rekriteFaz 1/2
  • The University of Kansas Hospital, Westwood · 5 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Jan 30, 2026 · NCT06926920

Etid Kansè tete negatif triple nan lòt vil

Lòt etid nan Kansas City

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.